The research group of Xinjing Tang developed efficient inhibition of SARS-CoV-2 using chimeric oligonucleotides through RNase L activation

Journal of Chinese Pharmaceutical Sciences ›› 2021, Vol. 30 ›› Issue (7): 621-622.

The research group of Xinjing Tang developed efficient inhibition of SARS-CoV-2 using chimeric oligonucleotides through RNase L activation

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2021-07-22 Revised:2021-07-23 Accepted:2021-07-24 Online:2021-07-27 Published:2021-07-30

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research group of Xinjing Tang developed efficient inhibition of SARS-CoV-2 using chimeric oligonucleotides through RNase L activation[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(7): 621-622.

The research group of Xinjing Tang developed efficient inhibition of SARS-CoV-2 using chimeric oligonucleotides through RNase L activation

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments